These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 17510533)

  • 1. Frequent DNA methylation but not mutation of the ID4 gene in malignant lymphoma.
    Hagiwara K; Nagai H; Li Y; Ohashi H; Hotta T; Saito H
    J Clin Exp Hematop; 2007 Apr; 47(1):15-8. PubMed ID: 17510533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitor of DNA binding 4 functions as a tumor suppressor and is targetable by 5-aza-2'-deoxycytosine with potential therapeutic significance in Burkitt's lymphoma.
    Gao XZ; Zhao WG; Wang GN; Cui MY; Zhang YR; Li WC
    Mol Med Rep; 2016 Feb; 13(2):1269-74. PubMed ID: 26648013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant hypermethylation of ID4 gene promoter region increases risk of lymph node metastasis in T1 breast cancer.
    Umetani N; Mori T; Koyanagi K; Shinozaki M; Kim J; Giuliano AE; Hoon DS
    Oncogene; 2005 Jul; 24(29):4721-7. PubMed ID: 15897910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic inactivation of inhibitor of differentiation 4 (Id4) correlates with prostate cancer.
    Sharma P; Chinaranagari S; Patel D; Carey J; Chaudhary J
    Cancer Med; 2012 Oct; 1(2):176-86. PubMed ID: 23342267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ABF-1 is frequently silenced by promoter methylation in follicular lymphoma, diffuse large B-cell lymphoma and Burkitt's lymphoma.
    Ushmorov A; Leithäuser F; Ritz O; Barth TF; Möller P; Wirth T
    Leukemia; 2008 Oct; 22(10):1942-4. PubMed ID: 18368067
    [No Abstract]   [Full Text] [Related]  

  • 6. [Methylation of Id4 gene promoter in 4 malignant hematopoietic cell lines].
    Zhao Y; Wang QS; Li HH; Jing Y; Bo J; Wang SH; Yu L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Dec; 16(6):1418-20. PubMed ID: 19099656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Promoter hypermethylation of the DNA-repair gene O6-methylguanine-DNA methyltransferase and p53 mutation in diffuse large B-cell lymphoma.
    Hiraga J; Kinoshita T; Ohno T; Mori N; Ohashi H; Fukami S; Noda A; Ichikawa A; Naoe T
    Int J Hematol; 2006 Oct; 84(3):248-55. PubMed ID: 17050200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitor of differentiation 4 (Id4) is a potential tumor suppressor in prostate cancer.
    Carey JP; Asirvatham AJ; Galm O; Ghogomu TA; Chaudhary J
    BMC Cancer; 2009 Jun; 9():173. PubMed ID: 19500415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between lymphoma prognosis and aberrant methylation of ID4 and ZO-1 in bone marrow and paraffin-embedded lymphoma tissues of treatment-naive patients.
    Cen J; Shen J; Wang X; Kang H; Wang L; Sun L; Li Y; Yu L
    Oncol Rep; 2013 Jul; 30(1):455-61. PubMed ID: 23670122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic regulation of ID4 in breast cancer: tumor suppressor or oncogene?
    Nasif D; Campoy E; Laurito S; Branham R; Urrutia G; Roqué M; Branham MT
    Clin Epigenetics; 2018 Aug; 10(1):111. PubMed ID: 30139383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulation of ID4 by promoter hypermethylation in gastric adenocarcinoma.
    Chan AS; Tsui WY; Chen X; Chu KM; Chan TL; Chan AS; Li R; So S; Yuen ST; Leung SY
    Oncogene; 2003 Oct; 22(44):6946-53. PubMed ID: 14534543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Promoter methylation-associated loss of ID4 expression is a marker of tumour recurrence in human breast cancer.
    Noetzel E; Veeck J; Niederacher D; Galm O; Horn F; Hartmann A; Knüchel R; Dahl E
    BMC Cancer; 2008 May; 8():154. PubMed ID: 18513385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Silencing of the inhibitor of DNA binding protein 4 (ID4) contributes to the pathogenesis of mouse and human CLL.
    Chen SS; Claus R; Lucas DM; Yu L; Qian J; Ruppert AS; West DA; Williams KE; Johnson AJ; Sablitzky F; Plass C; Byrd JC
    Blood; 2011 Jan; 117(3):862-71. PubMed ID: 21098398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inactivation of the lamin A/C gene by CpG island promoter hypermethylation in hematologic malignancies, and its association with poor survival in nodal diffuse large B-cell lymphoma.
    Agrelo R; Setien F; Espada J; Artiga MJ; Rodriguez M; Pérez-Rosado A; Sanchez-Aguilera A; Fraga MF; Piris MA; Esteller M
    J Clin Oncol; 2005 Jun; 23(17):3940-7. PubMed ID: 15867203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant DNA methylation of p57(KIP2) gene in the promoter region in lymphoid malignancies of B-cell phenotype.
    Li Y; Nagai H; Ohno T; Yuge M; Hatano S; Ito E; Mori N; Saito H; Kinoshita T
    Blood; 2002 Oct; 100(7):2572-7. PubMed ID: 12239171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Promoter methylation of ID4. A marker for recurrence-free survival in human breast cancer].
    Noetzel E; Veeck J; Horn F; Hartmann A; Knüchel R; Dahl E
    Pathologe; 2008 Nov; 29 Suppl 2():319-27. PubMed ID: 18807039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Significance of id4 gene promoter methylation detection in lymphoma].
    Zhao Y; Jing Y; Bo J; Wang SH; Wang QS; Li HH; Yu L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Apr; 16(2):322-4. PubMed ID: 18426657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitor of differentiation 4 (ID4) acts as an inhibitor of ID-1, -2 and -3 and promotes basic helix loop helix (bHLH) E47 DNA binding and transcriptional activity.
    Sharma P; Chinaranagari S; Chaudhary J
    Biochimie; 2015 May; 112():139-50. PubMed ID: 25778840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The many layers of epigenetic dysfunction in B-cell lymphomas.
    Jiang Y; Dominguez PM; Melnick AM
    Curr Opin Hematol; 2016 Jul; 23(4):377-84. PubMed ID: 27055146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methylation changes of SIRT1, KLF4, DAPK1 and SPG20 in B-lymphocytes derived from follicular and diffuse large B-cell lymphoma.
    Frazzi R; Zanetti E; Pistoni M; Tamagnini I; Valli R; Braglia L; Merli F
    Leuk Res; 2017 Jun; 57():89-96. PubMed ID: 28324774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.